Update: 10.09.2024
Last week: 35 week 2024 (26.08.2024 - 01.09.2024)
Last full month: August 2024
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | |||||||||
| WoW | 8 318 | 0.4% | 13.7% | 0.5 | 15 431 610 | 0.9% | 9.6% | 0.4 | -3.2% |
| MoM | 35 261 | 5.1% | 13.5% | 0.3 | 65 816 842 | 1.7% | 9.5% | -0.1 | 2.4% |
| YTD | 256 680 | 21.6% | 11.7% | 2.9 | 543 786 115 | 38.7% | 9.4% | 2.1 | -8.4% |
| MAT | 386 354 | 24.6% | 11.0% | 2.2 | 808 535 579 | 41.6% | 9.0% | 1.7 | -1.0% |
| BRAINMAX | |||||||||
| WoW | 1 491 | 16.5% | 100.0% | 0 | 5 798 689 | 18.8% | 100.0% | 0 | 16.5% |
| MoM | 5 740 | 10.1% | 100.0% | 0 | 22 114 768 | 12.8% | 100.0% | 0 | 12.4% |
| YTD | 38 154 | 41.2% | 100.0% | 0 | 140 726 158 | 53.3% | 100.0% | 0 | 41.2% |
| MAT | 57 778 | 57.1% | 100.0% | 0 | 209 950 407 | 70.7% | 100.0% | 0 | 57.1% |
| GOLDLINE PLUS | |||||||||
| WoW | 14 256 | -10.5% | 45.2% | -0.2 | 44 100 868 | -12.1% | 36.6% | -1 | -10.1% |
| MoM | 65 862 | -3.2% | 45.6% | -0.7 | 204 367 766 | -3.8% | 37.6% | -0.6 | -1.6% |
| YTD | 585 019 | -5.0% | 45.0% | 0.6 | 1 841 154 034 | -2.3% | 36.8% | -2.8 | -6.3% |
| MAT | 838 336 | 0.5% | 45.4% | 0.8 | 2 648 778 925 | 5.5% | 37.7% | -1.9 | -1.2% |
| MIGRENIUM | |||||||||
| WoW | 11 224 | -9.2% | 0.5% | 0 | 3 731 282 | -8.8% | 0.6% | 0 | -4.1% |
| MoM | 52 363 | 14.4% | 0.5% | 0 | 17 438 969 | 13.0% | 0.7% | 0 | 5.1% |
| YTD | 411 337 | -8.7% | 0.5% | -0.1 | 128 140 035 | 56.0% | 0.7% | 0.2 | 7.4% |
| MAT | 602 148 | -9.1% | 0.5% | -0.1 | 168 670 046 | 39.8% | 0.6% | 0.1 | 10.5% |
| MODELAX-N | |||||||||
| WoW | 23 565 | -10.0% | 19.4% | 0 | 11 009 007 | -10.2% | 12.8% | -0.2 | -9.8% |
| MoM | 107 491 | 4.4% | 19.5% | 0.2 | 50 399 196 | 4.7% | 12.9% | -0.1 | 3.5% |
| YTD | 1 009 522 | 32.3% | 22.6% | 4 | 437 470 375 | 81.8% | 14.6% | 4.2 | 9.2% |
| MAT | 1 414 719 | 49.9% | 21.3% | 5 | 579 703 654 | 92.0% | 13.2% | 4.1 | 14.4% |
| REDUXIN | |||||||||
| WoW | 10 586 | -7.7% | 33.6% | 0.9 | 55 136 327 | -7.3% | 45.8% | 1.2 | -10.1% |
| MoM | 47 269 | -1.9% | 32.8% | -0.1 | 241 692 826 | -2.4% | 44.5% | -0.1 | -1.6% |
| YTD | 427 967 | -8.2% | 32.9% | -0.7 | 2 284 412 003 | 13.0% | 45.7% | 3.2 | -6.3% |
| MAT | 599 520 | -5.3% | 32.4% | -1.4 | 3 135 641 104 | 16.2% | 44.6% | 2.1 | -1.2% |
| REDUXIN FORTE | |||||||||
| WoW | 3 109 | -10.4% | 9.9% | 0 | 13 167 912 | -8.6% | 10.9% | 0.1 | -10.1% |
| MoM | 13 962 | 2.0% | 9.7% | 0.3 | 58 566 373 | 1.0% | 10.8% | 0.3 | -1.6% |
| YTD | 115 816 | 0.2% | 8.9% | 0.6 | 500 291 446 | 12.9% | 10.0% | 0.7 | -6.3% |
| MAT | 166 296 | 8.5% | 9.0% | 0.8 | 710 515 216 | 20.7% | 10.1% | 0.8 | -1.2% |
| SALVISAR | |||||||||
| WoW | 9 293 | -3.4% | 1.2% | 0 | 3 932 370 | -4.1% | 1.1% | 0 | -5.7% |
| MoM | 39 431 | 12.9% | 1.2% | 0.1 | 16 898 831 | 7.9% | 1.1% | 0 | 7.0% |
| YTD | 347 341 | 2.1% | 1.3% | 0.1 | 141 951 651 | 27.6% | 1.2% | 0.1 | -1.7% |
| MAT | 505 638 | -10.4% | 1.3% | -0.2 | 194 463 723 | 2.7% | 1.1% | -0.2 | 2.1% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 256 680 | 21.6% | 11.7% | 2.9 | 543 786 115 | 38.7% | 9.4% | 2.1 | -8.4% |
| BRAINMAX | 38 154 | 41.2% | 100.0% | 0 | 140 726 158 | 53.3% | 100.0% | 0 | 41.2% |
| GOLDLINE PLUS | 585 019 | -5.0% | 45.0% | 0.6 | 1 841 154 034 | -2.3% | 36.8% | -2.8 | -6.3% |
| MIGRENIUM | 411 337 | -8.7% | 0.5% | -0.1 | 128 140 035 | 56.0% | 0.7% | 0.2 | 7.4% |
| MODELAX-N | 1 009 522 | 32.3% | 22.6% | 4 | 437 470 375 | 81.8% | 14.6% | 4.2 | 9.2% |
| REDUXIN CAPS | 427 967 | -8.2% | 32.9% | -0.7 | 2 284 412 003 | 13.0% | 45.7% | 3.2 | -6.3% |
| REDUXIN FORTE | 115 816 | 0.2% | 8.9% | 0.6 | 500 291 446 | 12.9% | 10.0% | 0.7 | -6.3% |
| SALVISAR | 347 341 | 2.1% | 1.3% | 0.1 | 141 951 651 | 27.6% | 1.2% | 0.1 | -1.7% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 386 354 | 24.6% | 11.0% | 2.2 | 808 535 579 | 41.6% | 9.0% | 1.7 | -1.0% |
| BRAINMAX | 57 778 | 57.1% | 100.0% | 0 | 209 950 407 | 70.7% | 100.0% | 0 | 57.1% |
| GOLDLINE PLUS | 838 336 | 0.5% | 45.4% | 0.8 | 2 648 778 925 | 5.5% | 37.7% | -1.9 | -1.2% |
| MIGRENIUM | 602 148 | -9.1% | 0.5% | -0.1 | 168 670 046 | 39.8% | 0.6% | 0.1 | 10.5% |
| MODELAX-N | 1 414 719 | 49.9% | 21.3% | 5 | 579 703 654 | 92.0% | 13.2% | 4.1 | 14.4% |
| REDUXIN CAPS | 599 520 | -5.3% | 32.4% | -1.4 | 3 135 641 104 | 16.2% | 44.6% | 2.1 | -1.2% |
| REDUXIN FORTE | 166 296 | 8.5% | 9.0% | 0.8 | 710 515 216 | 20.7% | 10.1% | 0.8 | -1.2% |
| SALVISAR | 505 638 | -10.4% | 1.3% | -0.2 | 194 463 723 | 2.7% | 1.1% | -0.2 | 2.1% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 8 318 | 0.4% | 13.7% | 0.5 | 15 431 610 | 0.9% | 9.6% | 0.4 | -3.2% |
| BRAINMAX | 1 491 | 16.5% | 100.0% | 0 | 5 798 689 | 18.8% | 100.0% | 0 | 16.5% |
| GOLDLINE PLUS | 14 256 | -10.5% | 45.2% | -0.2 | 44 100 868 | -12.1% | 36.6% | -1 | -10.1% |
| MIGRENIUM | 11 224 | -9.2% | 0.5% | 0 | 3 731 282 | -8.8% | 0.6% | 0 | -4.1% |
| MODELAX-N | 23 565 | -10.0% | 19.4% | 0 | 11 009 007 | -10.2% | 12.8% | -0.2 | -9.8% |
| REDUXIN CAPS | 10 586 | -7.7% | 33.6% | 0.9 | 55 136 327 | -7.3% | 45.8% | 1.2 | -10.1% |
| REDUXIN FORTE | 3 109 | -10.4% | 9.9% | 0 | 13 167 912 | -8.6% | 10.9% | 0.1 | -10.1% |
| SALVISAR | 9 293 | -3.4% | 1.2% | 0 | 3 932 370 | -4.1% | 1.1% | 0 | -5.7% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 35 261 | 5.1% | 13.5% | 0.3 | 65 816 842 | 1.7% | 9.5% | -0.1 | 2.4% |
| BRAINMAX | 5 740 | 10.1% | 100.0% | 0 | 22 114 768 | 12.8% | 100.0% | 0 | 12.4% |
| GOLDLINE PLUS | 65 862 | -3.2% | 45.6% | -0.7 | 204 367 766 | -3.8% | 37.6% | -0.6 | -1.6% |
| MIGRENIUM | 52 363 | 14.4% | 0.5% | 0 | 17 438 969 | 13.0% | 0.7% | 0 | 5.1% |
| MODELAX-N | 107 491 | 4.4% | 19.5% | 0.2 | 50 399 196 | 4.7% | 12.9% | -0.1 | 3.5% |
| REDUXIN CAPS | 47 269 | -1.9% | 32.8% | -0.1 | 241 692 826 | -2.4% | 44.5% | -0.1 | -1.6% |
| REDUXIN FORTE | 13 962 | 2.0% | 9.7% | 0.3 | 58 566 373 | 1.0% | 10.8% | 0.3 | -1.6% |
| SALVISAR | 39 431 | 12.9% | 1.2% | 0.1 | 16 898 831 | 7.9% | 1.1% | 0 | 7.0% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе “MS of competitors” в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection “MS of competitors” in sections for each brand
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #90"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #10"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #30"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #60"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #90"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
## [1] "BRAINMAX"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе “MS of competitors” в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection “MS of competitors” in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs